Cargando…
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
BACKGROUND: There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as...
Autores principales: | Brettschneider, Johannes, Czerwoniak, Anne, Senel, Makbule, Fang, Lubin, Kassubek, Jan, Pinkhardt, Elmar, Lauda, Florian, Kapfer, Tamara, Jesse, Sarah, Lehmensiek, Vera, Ludolph, Albert C., Otto, Markus, Tumani, Hayrettin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916843/ https://www.ncbi.nlm.nih.gov/pubmed/20700489 http://dx.doi.org/10.1371/journal.pone.0011986 |
Ejemplares similares
-
The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis
por: Dersch, R, et al.
Publicado: (2015) -
Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report
por: Rapp, Daniel, et al.
Publicado: (2020) -
Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014) -
IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome
por: Brettschneider, Johannes, et al.
Publicado: (2009) -
Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
por: Huss, André, et al.
Publicado: (2020)